Wordt geladen...
Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
Gastrointestinal stromal tumors (GIST) are rare and mesenchymal in origin with a yearly incidence of 10‐15 cases per million people. If it is technically resectable, surgical resection is the mainstay of therapy regardless of tumor location,. Although complete (R0) resection can be achieved in up to...
Bewaard in:
| Gepubliceerd in: | Ann Gastroenterol Surg |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6345649/ https://ncbi.nlm.nih.gov/pubmed/30697609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12211 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|